World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 April 2013
Main ID:  PACTR2009110001673419
Date of registration: 22/10/2009
Primary sponsor: Christian Wejse
Public title: PREDINAM
Scientific title: TBscore and suPAR used to PREDict and INtervene Against high Mortality (PREDINAM) - a randomised trial
Date of first enrolment:
Target sample size:
Recruitment status: Temporary halt or suspension
URL:  HTTP://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR2009110001673419
Study type:  interventional
Study design:  Parallel: different groups receive different interventions at same time during study,
Randomised,
Simple randomisation using a radomisation table created by a computer software program,
Allocation was determined by the holder of the sequence who is situated off site,
 
Countries of recruitment
South Africa
Contacts
Name: Frauke  Rudolf
Address:  apartado 861 1004 Bissau Codex Guinea-Bisseu
Telephone: + 245 6895169
Email: frauke.rudolf@ki.au.dk
Affiliation:  MD PhD student
Name: Christian  Wejse
Address:  Department of infectious diseases Skejby sygehus, Aarhus University Hospital Brendstrupg?rdsvej 8200 ?rhus N Denmark
Telephone: Phone: +45-89498492
Email: wejse@dadlnet.dk
Affiliation:  PhD/Supervisor
Key inclusion & exclusion criteria
Inclusion criteria: - adults (b 15 years)
- At least one symptom indicating possible TB: 3 weeks of cough, sputum production or weight loss.
- Residents or long-term guests of Bandim I, Bandim II, Belem, Mindara and Cuntum.

Exclusion criteria: None


Age minimum: 15 Year
Age maximum: 100 Year
Gender: Both
Health Condition(s) or Problem(s) studied

HIV/AIDS
Tuberculosis
null
Intervention(s)
Primary Outcome(s)
12 month overall mortality in the high risk group with TBscore?8 or suPAR?4
Secondary Outcome(s)
Weight gain, haemoglobin increase, TBscore/suPAR decrease
Secondary ID(s)
Ulandsprojekt Sagsnr. 0907691
Source(s) of Monetary Support
Frimodt-Heineke Fonden
A P M?ller fonden (l?gev. Fremme)
Jacob og Olga Madsen Fond
EDCTP
Klinisk Forskningscenter Hvidovre
?rhus Universitets Forskningsfond
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history